Amid Coronavirus Rally, Israeli Biotech Taps Wall St.

Companies have or are poised to raise nearly $500 million in initial or secondary offerings

Eran Azran
Send in e-mailSend in e-mail
A staff member manipulates samples on at a laboratory of the walk-in testing center of German biotech company Centogene at the airport in Frankfurt am Main, June 30, 2020
A staff member manipulates samples on at a laboratory of the walk-in testing center of German biotech company Centogene at the airport in Frankfurt am Main, June 30, 2020 Credit: AFP

Comments